छोड़कर सामग्री पर जाएँ

Latest News

Buy Cholamandalam Investment and Finance Company; target of Rs 1350: Sharekhan

Buy Cholamandalam Investment and Finance Company; target of Rs 1350: Sharekhan

Sharekhan is bullish on Cholamandalam Investment and Finance Company has recommended buy rating on the stock with a target price of Rs 1350 in its research report dated October 03, 2023. Read More ​ Sharekhan is bullish on Cholamandalam Investment and… और पढ़ें »Buy Cholamandalam Investment and Finance Company; target of Rs 1350: Sharekhan

Metropolis Healthcare Q2 results: Net Profit down 11.9% to Rs 35.5 crore

Metropolis Healthcare Q2 results: Net Profit down 11.9% to Rs 35.5 crore

The diagnostic services provider#39;s operations predominantly relate to providing diagnostic services in pathology services. Read More ​ The diagnostic services provider#39;s operations predominantly relate to providing diagnostic services in pathology services. The diagnostic services provider#39;s operations predominantly relate to providing diagnostic… और पढ़ें »Metropolis Healthcare Q2 results: Net Profit down 11.9% to Rs 35.5 crore

Divi#39;s Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix

Divi#39;s Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix

A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs Read More ​ A high base from the sales of COVID drug Molnupiravir and soft demand is likely… और पढ़ें »Divi#39;s Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix

IPO Weekly Wrap: Mamaearth, ESAF, Cello, Blue Jet and 12 SMEs steer the market ship

IPO Weekly Wrap: Mamaearth, ESAF, Cello, Blue Jet and 12 SMEs steer the market ship

Mamaearth#39;s parent company, Honasa Consumer, and Cello World concluded their public issues this week Read More ​ Mamaearth#39;s parent company, Honasa Consumer, and Cello World concluded their public issues this week Mamaearth#39;s parent company, Honasa Consumer, and Cello World concluded their… और पढ़ें »IPO Weekly Wrap: Mamaearth, ESAF, Cello, Blue Jet and 12 SMEs steer the market ship

One billion bipedal robots to AI-based doctors: Ace entrepreneur Vinod Khosla#39;s predictions for upcoming decades

One billion bipedal robots to AI-based doctors: Ace entrepreneur Vinod Khosla#39;s predictions for upcoming decades

Right from the growth of one billion bipedal robots in the next 25 years to finding efficient sources of plant protein to replace animal protein, these predictions mostly encircle technology and AI that will soon reinvent societal structure. Read More… और पढ़ें »One billion bipedal robots to AI-based doctors: Ace entrepreneur Vinod Khosla#39;s predictions for upcoming decades

hi_INहिन्दी